Communiqués HYTN Innovations Inc.

Actions

HYTN

CA40443L1040

Marché Fermé - Canadian Securities Exchange Autres places de cotation 21:41:11 20/06/2024			Varia. 5j.	Varia. 1 janv.
0,41 ^CAD	0,00%		+5,13%	+485,71%

30/05	HYTN Innovations Inc. présente ses résultats pour le deuxième trimestre et le semestre clos le 31 mars 2024	CI
29/02	HYTN Innovations Inc. annonce ses résultats pour le premier trimestre clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

HYTN Welcomes U.S. Recommendation to Reclassify Cannabis, Foresees Growth	01/05	AQ
HYTN Innovations : 2024 Annual General Meeting Documents	26/04	PU
HYTN Innovates GMP Stability Programs, Sets Industry Benchmark	22/04	AQ
HYTN Welcomes Health Canada for Audit to Enhance GMP Capabilities	09/04	AQ
HYTN Innovations : SECURES GMP CERTIFICATION	05/04	PU
HYTN Provides Corporate Update, Outlines New Global Direction	03/04	AQ
HYTN Secures GMP Certification	21/03	AQ
HYTN Clears PIC/S GMP Audit, Primed for Global Expansion	04/03	AQ
HYTN Broadens Reach with Innovative Cannabis-Infused Nano Shot	20/02	AQ
HYTN Announces Closing of Non-Brokered Private Placement Under Listed Issuer Financing Exemption	26/10/23	AQ
HYTN Innovations : Announces Non-Brokered Private Placement Under Listed IssuerFinancing Exemption	27/09/23	PU
HYTN Innovations expands its Controlled Drugs and Substances Dealers License to include MDMA and Ketamine	02/03/23	AQ
HYTN Innovations Cultivates Psilocybin Mushrooms and Upgrades Equipment for API Development	23/02/23	AQ
HYTN Innovations Advances Active Pharmaceutical Ingredient Portfolio and Increases Sales of Rapid Onset Cannabis Products Using Proprietary Elevation Technology	16/02/23	AQ
HYTN Sells Out of Innovative Holiday Products	30/11/22	AQ
HYTN Initiates Sale of Cannabis Products in Quebec Through Agreement With Rose	24/10/22	AQ
HYTN Awarded Controlled Drugs and Substances Dealer’s License Allowing for Production and Sale of Psilocybin	17/10/22	AQ
HYTN Opens Provincial and Territorial Markets for Tricanna Manufactured Pre-Rolled Cannabis Products	29/09/22	AQ
HYTN Announces Launch of Rapid Onset Nano Gummies and Provides Commercial Update	29/08/22	AQ
HYTN Awarded Medical Cannabis Sales Licence Increasing Opportunities at Kelowna Facility	23/08/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués HYTN Innovations Inc.

Actions

HYTN

CA40443L1040

Communiqués

Filtres